Research ArticleInfluenza

Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity

See allHide authors and affiliations

Science Translational Medicine  14 Feb 2018:
Vol. 10, Issue 428, eaan8405
DOI: 10.1126/scitranslmed.aan8405

Article Information

vol. 10 no. 428

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication May 26, 2017
  • Resubmitted September 5, 2017
  • Accepted for publication December 22, 2017
  • .

Author Information

  1. Marios Koutsakos1,
  2. Adam K. Wheatley1,
  3. Liyen Loh1,
  4. E. Bridie Clemens1,
  5. Sneha Sant1,
  6. Simone Nüssing1,
  7. Annette Fox1,
  8. Amy W. Chung1,
  9. Karen L. Laurie2,
  10. Aeron C. Hurt2,
  11. Steve Rockman1,3,
  12. Martha Lappas4,
  13. Thomas Loudovaris5,
  14. Stuart I. Mannering5,
  15. Glen P. Westall6,
  16. Michael Elliot7,8,
  17. Stuart G. Tangye9,10,
  18. Linda M. Wakim1,
  19. Stephen J. Kent1,11,12,
  20. Thi H. O. Nguyen1,*, and
  21. Katherine Kedzierska1,*,
  1. 1Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, Victoria 3010, Australia.
  2. 2World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia.
  3. 3Seqirus, 63 Poplar Road, Parkville, Victoria 3052, Australia.
  4. 4Obstetrics, Nutrition and Endocrinology Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria 3084, Australia.
  5. 5Immunology and Diabetes Unit, St Vincent’s Institute of Medical Research, Fitzroy, Victoria 3065, Australia.
  6. 6Lung Transplant Unit, Alfred Hospital, Melbourne, Victoria 3004, Australia.
  7. 7Sydney Medical School, University of Sydney, Sydney, New South Wales 2006, Australia.
  8. 8Chris O’Brien Lifehouse Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia.
  9. 9Immunology Division, Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia.
  10. 10St Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales 2052, Australia.
  11. 11Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria 3004, Australia.
  12. 12ARC Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Parkville, Victoria 3010, Australia.
  1. Corresponding author. Email: kkedz{at}unimelb.edu.au (K.K.); tho.nguyen{at}unimelb.edu.au (T.H.O.N.)
    • * These authors contributed equally to this work.

    Altmetric

    Article usage

    Article usage: March 2018 to September 2020

    AbstractFullPdf
    Feb 20187603307740
    Mar 201872958155
    Apr 20183635396
    May 201847337101
    Jun 20184212462
    Jul 20182853956
    Aug 201851911450
    Sep 20181285348
    Oct 20181274445
    Nov 20181544641
    Dec 20181284537
    Jan 20191235073
    Feb 201980208119
    Mar 2019312482
    Apr 2019511780
    May 20191111874
    Jun 201912126109
    Jul 201918102112
    Aug 201997759
    Sep 2019139395
    Oct 2019137371
    Nov 2019579106
    Dec 201976243
    Jan 2020411783
    Feb 20209125121
    Mar 20204228176
    Apr 20201178195
    May 20203129142
    Jun 20207104103
    Jul 2020110074
    Aug 202038985
    Sep 20207111133

    Stay Connected to Science Translational Medicine

    Navigate This Article